Confronting the Complexity of Global Healthcare

WALTHAM, Mass., September 23, 2021 /PRNewswire/ — Fresenius Medical Care, the world’s leading provider of products and services for people with kidney disease, has announced the release of its 2021 Global Annual Medical Report. Titled “Embracing the Complexity of Global Healthcare”, the report focuses on solving the complexities of healthcare by significantly advancing kidney disease care.

(PRNewsfoto/Fresenius <a class=Medical Care North Am)” src=”–/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1Mg–/–~B/aD04Njt3PTQwMDthcHBpZD15dGFjaHlvbg–/″/>

(PRNewsfoto/Fresenius Medical Care North Am)

“The volume of thought leadership, ideas and expertise in the report demonstrates our company’s continued leadership in kidney care, our innovation through lifelong learning and our commitment to our core mission. the patient,” said Franklin W. MadduxMD, Global Medical Director of Fresenius Medical Care.

The 2021 Global Annual Medical Report includes 25 chapters written by more than 40 authors from across the company. Six different sections each focus on a central theme of Fresenius Medical Care’s clinical and quality agenda. An additional COVID-19 section is dedicated to the company’s ongoing efforts to address the pandemic.

The central themes are:

The Global Annual Medical Report 2021 is published by the global medical office of Fresenius Medical Care. The full report is now available online at:

Fresenius Medical Care is the world’s leading provider of products and services for people with kidney disease, of whom approximately 3.7 million patients worldwide regularly undergo dialysis treatment. Through its network of more than 4,100 dialysis clinics, Fresenius Medical Care provides dialysis treatment to approximately 346,000 patients worldwide. Fresenius Medical Care is also the main supplier of dialysis products such as dialysis machines or dialyzers. Along with its core business, the renal care continuum, the company is focused on expanding into complementary areas and into the critical care space. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS).

For more information, visit the company’s website at

This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to a variety of factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, impacts related to the results of the COVID-19 pandemic from clinical studies, exchange rate fluctuations, uncertainties in legal or investigative proceedings and the availability of funding. These and other risks and uncertainties are detailed in Fresenius Medical Care AG & Co. KGaA’s reports filed with the United States Securities and Exchange Commission. Fresenius Medical Care AG & Co. KGaA disclaims any responsibility for updating the forward-looking statements contained in this release.

Media Contact
Michael Gavin
T +49 6172 609-2978
[email protected]

Media contact for North America
Brad Puffer
T +1 781-699-3331
[email protected]

Contact for analysts and investors
dr. Dominik Heger
T +49 6172 609-2601
[email protected]



View original content to download multimedia: -healthcare-301383356.html

SOURCE Fresenius Medical Care Holdings, Inc.